Inverse association of leptin levels with renal cell carcinoma: Results from a case-control study

Hormones

Volumn 8, Issue 1, 2009, Pages 39-46

  Spyridopoulos, Themistoklis N ^a   Petridou, Eleni Th ^a,b   Dessypris, Nick ^a   Terzidis, Agapios ^a   Skalkidou, Alkistis ^a,c   Deliveliotis, Charalambos ^d   Chrousos, George P ^a   Giannopoulos, A ^a   Alivizatos, G ^a   Vassilakis, G ^e   Kalogeropoulos, T ^f  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF ATHENS   (Greece)

^e G GENNIMATAS GENERAL HOSPITAL   (Greece)

^f SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Adiponectin; Immunity; Inflammation; Leptin; Obesity; Renal cell carcinoma

Indexed keywords

ADIPONECTIN; HORMONE; LEPTIN;

ADIPOSE TISSUE; ADULT; AGED; ANAMNESIS; ANTHROPOMETRY; ARTICLE; BODY MASS; CHRONIC INFLAMMATION; CONTROLLED STUDY; DIABETES MELLITUS; FEEDING BEHAVIOR; FEMALE; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INTERVIEW; KIDNEY CARCINOMA; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PLASMA; RISK FACTOR; WEIGHT CHANGE; BLOOD; CASE CONTROL STUDY; KIDNEY TUMOR; MIDDLE AGED; RISK ASSESSMENT;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; KIDNEY NEOPLASMS; LEPTIN; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 63049109002     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1220     Document Type: Article

References (28)

1. Lipworth L, Tarone RE, McLaughlin JK, 2006 The epidemiology of renal cell carcinoma. J Urol 176: 2353-2358.
2. Matarese G, Moschos S, Mantzoros CS, 2005 Leptin in Immunology. J Immunol 173: 3137-3142.
3. Shamsuzzaman AS, Winnicki M, Wolk R, et al, 2004 Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 109: 2181-2185. (Pubitemid 38625394)
4. De Rosa V, Procaccini C, Gaetano C, et al, 2007 A key role of leptin in the control of regulatory T cell proliferation. Immunity 26: 241-255. (Pubitemid 46329441)
5. La Cava A, Alviggi C, Matarese G, 2004 Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med 82: 4-11. (Pubitemid 38168097)
6. Horiguchi A, Sumitomo M, Asakuma J, et al, 2006 Increased serum levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma. J Urol 176: 1631-1635. (Pubitemid 44307222)
7. Horiguchi A, Sumitomo M, Asakuma J, et al, 2006 Leptin promotes invasiveness of murine renal cancer cells via extracellular signal-regulated kinases and rho dependent pathway. J Urol 176: 1636-1641. (Pubitemid 44316854)
8. Attoub S, Noe V, Pirola L, et al, 2000 Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. Faseb J 14: 2329-2338. (Pubitemid 30843929)
9. Spyridopoulos TN, Petridou E.Th, Skalkidou A, et al, 2007 Low adiponectin levels are associated with renal carcinoma: A case-control study. Int J Cancer 120: 1573-1578. (Pubitemid 46355396)
10. Gogas H, Trakatelli M, Dessypris N, et al, 2008 Melanoma risk in association with serum leptin levels and lifestyle parameters: a case-control study. Ann Oncol 19: 384-389. (Pubitemid 351201725)
11. Gnardellis C, Trichopoulou A, Katsouyanni K, Polychronopoulos E, Rimm EB, Trichopoulos D, 1995 Reproducibility and validity of an extensive semiquantitative food frequency questionnaire among Greek school teachers. Epidemiology 6: 74-77.
12. Petridou E, Kedikoglou S, Koukoulomatis P, et al, 2002 Diet in relation to endometrial cancer risk: a case-control study in Greece. Nutr Cancer 44: 16-22. (Pubitemid 36359316)
13. Petridou E, Ntouvelis E, Dessypris N, Terzidis A, Trichopoulos A, the Childhood Hematology-Oncology Group, 2005 Maternal diet and acute lymphoblastic leukemia in young children. Cancer Epidemiol Biomarkers Prev 14: 1935-1939.
14. Gavrila A, Chan JL, Yiannakouris N, et al, 2003 Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting of leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 88: 4823-4831. (Pubitemid 37357532)
15. SAS Institute Inc. 1989 SAS/ STAT User's Guide, Version 6, 4th Ed. Cary NC.
16. Petridou E, Papadiamantis Y, Markopoulos C, et al, 2000 Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control 11: 383-388. (Pubitemid 30345235)
17. Petridou E, Belechri M, Dessypris N, et al, 2002 Leptin and body mass index in relation to endometrial cancer risk. Ann Nutr Metab 46: 147-151. (Pubitemid 34920698)
18. Stattin P, Lukanova A, Biessy C, et al, 2004 Obesity and colon cancer: does leptin provide a link? Int J Cancer 109: 149-152.
19. Stattin P, Soderberg S, Hallmans G, et al, 2001 Leptin is associated with increased prostate risk: a nested case-referent study. J Clin Endocrinol Metab 86: 1341-1345. (Pubitemid 32323026)
20. Steiner AA, Romanovsky AA, 2007 Leptin: At the crossroads of energy balance and systemic inflammation. Prog Lipid Res 46: 89-107.
21. Pinkney JH, Coppack SW, Mohamed-Ali V, 1998 Effect of isoprenaline on plasma leptin and lipolysis in humans. Clin Endocrinol 48: 407-411. (Pubitemid 28258812)
22. Federico A, Morgillo F, Tuccillo C, et al, 2007 Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121: 2381-2386. (Pubitemid 350022406)
23. Parker A, Cerhan JR, Lynch CF, et al, 2004 History of Urinary Tract Infection and Risk of Renal Cell Carcinoma. Am J Epidemiol 159: 42-48. (Pubitemid 38049420)
24. Bukur J, Malenica B, Huber C, Seliger B, 2003 Altered expression of nonclassical HLA class 1B antigens in human renal cell carcinoma and its association with impaired immune response. Human Immunology 64: 1081-1092. (Pubitemid 37413718)
25. Hu X, Juneja SC, Maihle NJ, et al, 2002 Leptin: a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94: 1704-1711. (Pubitemid 35446839)
26. Oelmann E, Haghgu S, Kulimova E, et al, 2003 Re: Leptin: a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 95: 1171-1173. (Pubitemid 37045397)
27. Elinav E, Abd-Elnabi A, Pappo O, et al, 2006 Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation. J Hepatol 44: 529-536. (Pubitemid 43227877)
28. Nave H, Mueller G, Siegmund B, et al, 2008 Resistance of JAK-2 dependent leptin signaling in NK cells - a novel mechanism of NK cell dysfunction in diet-induced obesity. Endocrinology doi:10.1210/en.2007-1516. (Pubitemid 351919580)